Brain tumor patients may sharpen thinking with At-Home rehab program

NCT ID NCT06468176

Recruiting now Symptom relief Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a remote cognitive rehabilitation program for adults with slow-growing brain tumors (grade 2 or 3 glioma) who often struggle with memory, attention, and thinking. About 187 participants will either receive the program or standard care. The goal is to see if the program improves how patients perceive their own thinking abilities and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE GLIOMA GRADE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioma grade II glioma grade III glioma malignant glioma neoplasm nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOMA, MALIGNANT

Contacts and locations

Locations

CHU Amiens
NOT_YET_RECRUITING

Amiens, France
CHU Bordeaux
NOT_YET_RECRUITING

Bordeaux, France
CHU Lyon
NOT_YET_RECRUITING

Lyon, France
CHU Nancy
NOT_YET_RECRUITING

Nancy, France
CHU Nîmes
NOT_YET_RECRUITING

Nîmes, France
Hôpital de la Timone
NOT_YET_RECRUITING

Marseille, France
Institut Claudius Régaud
NOT_YET_RECRUITING

Toulouse, 31059, France
Institut régional du Cancer de Montpellier
RECRUITING

Montpellier, Hérault, 34298, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.